Found: 7
Select item for more details and to access through your institution.
Population pharmacokinetics of levodopa in patients with Parkinson's disease treated with tolcapone.
- Published in:
- Clinical Pharmacology & Therapeutics, 2000, v. 67, n. 6, p. 610, doi. 10.1067/mcp.2000.106795
- By:
- Publication type:
- Article
Optimizing levodopa pharmacokinetics with multiple tolcapone doses in the elderly<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 1997, v. 62, n. 3, p. 300, doi. 10.1016/S0009-9236(97)90033-3
- By:
- Publication type:
- Article
Integrated pharmacokinetics and pharmacodynamics of the novel catechol-O-methyltransferase inhibitor tolcapone during first administration to humans<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 1995, v. 57, n. 5, p. 508, doi. 10.1016/0009-9236(95)90035-7
- By:
- Publication type:
- Article
The effect of tolcapone on the pharmacokinetics of benserazide.
- Published in:
- European Journal of Neurology, 1999, v. 6, n. 2, p. 211, doi. 10.1111/j.1468-1331.1999.tb00015.x
- By:
- Publication type:
- Article
Population pharmacokinetics of tolcapone in parkinsonian patients in dose finding studies.
- Published in:
- British Journal of Clinical Pharmacology, 2000, v. 49, n. 1, p. 39, doi. 10.1046/j.1365-2125.2000.00113.x
- By:
- Publication type:
- Article
Metabolism and excretion of tolcapone, a novel inhibitor of catechol-O-methyltransferase.
- Published in:
- British Journal of Clinical Pharmacology, 1999, v. 48, n. 4
- By:
- Publication type:
- Article
Lack of Interaction between Tolcapone and Tolbutamide in Healthy Volunteers.
- Published in:
- Journal of Clinical Pharmacology, 2000, v. 40, n. 5, p. 544, doi. 10.1177/009127000004000516
- By:
- Publication type:
- Article